Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy

BACKGROUND: The metastatic renal cell carcinoma (mRCC) patients treated with upfront cytoreductive nephrectomy combined with α-interferon yields additional overall survival (OS) benefits. It is unclear whether mRCC patients treated with vascular endothelial growth factor receptor-tyrosine kinase inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yan, Du, Chun-Xia, Zhang, Wen, Sun, Yong-Kun, Yang, Lin, Cui, Cheng-Xu, Chi, Yihe-Bali, Shou, Jian-Zhong, Zhou, Ai-Ping, Li, Chang-Ling, Ma, Jian-Hui, Wang, Jin-Wan, Sun, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804433/
https://www.ncbi.nlm.nih.gov/pubmed/26904986
http://dx.doi.org/10.4103/0366-6999.177001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804433/
https://www.ncbi.nlm.nih.gov/pubmed/26904986
http://dx.doi.org/10.4103/0366-6999.177001

Ejemplares similares